6 completed, 1 unknown. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Unknown 1 |
| Phase 2 | 3 | Completed 3 |
Follow Digna Biotech S.L.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I Gene Therapy Clinical Trial Using the Vector rAAV2/5-PBGD for the Treatment of Acute Intermittent Porphyria rAAV2/5-PBGD vector dosage 1, rAAV2/5-PBGD vector dosage 2, rAAV2/5-PBGD vector dosage 3 - Acute Intermittent Porphyria | Phase 1 | Completed | Digna Biotech S.L. | 8 | 2012-11-01 | 2014-12-18 |
| Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Cardiotrophin-1 in Healthy Volunteers recombinant human cardiotrophin-1, Placebo - Healthy | Phase 1 | Unknown | Digna Biotech S.L. | 33 | 2012-11-01 | 2013-07-30 |
| Observational Study of Acute Intermittent Porphyria Patients Acute Intermittent Porphyria | Completed | Digna Biotech S.L. | 9 | 2011-08-01 | 2014-03-12 | |
| A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C Interferon α-5, Interferon-α5 plus Interferon-α 2b, Interferon α-2b (INTRON® A) - Chronic Hepatitis C Virus Infection, Genotype 1 | Phase 1 / Phase 2 | Completed | Digna Biotech S.L. | 70 | 2010-05-01 | 2013-02-05 |
| Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study P144 cream - Skin Fibrosis | Phase 2 | Completed | ISDIN | 38 | 2008-07-01 | 2013-02-11 |
| Efficacy and Safety Study of p144 to Treat Skin Fibrosis in Systemic Sclerosis P144, placebo - Skin Fibrosis | Phase 2 | Completed | ISDIN | 56 | 2007-09-01 | 2013-02-11 |
| Tolerability and Bioavailability of the P144 Peptide Inhibitor of TGF-β1 After Topical Administration in Healthy Volunteers P144 cream, Placebo - Healthy | Phase 1 | Completed | ISDIN | 36 | 2007-03-01 | 2008-11-05 |
Scleroderma, Systemic (3) · Porphyria, Acute Intermittent (2) · Porphyrias (2) · Recurrence (1)
Introns (1)
Spain (7) · Germany (2) · Hungary (2) · Italy (2) · Poland (2) · United Kingdom (2)
Jesus Prieto, MD (2) · Juan Ruiz, MD (2) · Rafael Enriquez de Salamanca, MD (2) · Christopher Denton, MD (1) · Marco Matucci, MD (1) · Marco Matucci, MD, PhD (1) · Thomas Krieg, MD (1)
2008 (1), 2009 (1)